logo
Select company
Select metric
$ 2.2MStock Based Compensation
VS
Market
71
Sector
76
Industry
76
History
-
$ 13.62Close
$ 8.81 - $ 20.45 52-Week Range
Ticker Information

Ticker

CVKD

Company Name

CADRENAL THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CADRENAL THERAPEUTICS INC - Stock Based Compensation Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CVKD - SB Comp. Historical data
DateStock Based Compensation
6/30/2025$ 2.2M
3/31/2025$ 1.81M
12/31/2024$ 1.42M
9/30/2024$ 758.95K
6/30/2024$ 612.04K
3/31/2024$ 586.72K
12/31/2023$ 710.38K
9/30/2023$ 1.06M
6/30/2023$ 1.38M
12/31/2022$ 928.05K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Definition of Stock Based Compensation

[Cash Flow Statement] Stock Based Compensation, also called Share Based Compensation or Equity Compensation, is a method of paying directors, executives and employees with equity in the business. As non-cash expense, this element is added back when calculating net cash generated by operating activities [NCFO].

CVKD - Stock Based Compensation, Last 5 years

$ 586.72K

Minimum

Mar 31, 2024

$ 2.2M

Maximum

Jun 30, 2025

$ 1.15M

Average

$ 992.34K

Median

SB Comp. Benchmark Analysis

The chart above depicts the distribution of SB Comp. for companies in the Total Stock Market. The average SB Comp. of the companies is $ 12.15M with a standard deviation of $ 14.38M.
The following table provides additional summary stats:
SB Comp. in the Market:
filtered constituents3.51K
min$ -20.28M
max$ 59.43M
average$ 12.15M
median$ 6.38M
std$ 14.38M